Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin

Sponsor
Handok Inc.
Study ID
NCT04431141
Phase
PHASE1
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
19 Years - 45 Years
Healthy Volunteers
Accepted

Interventions

Study Details

This study is to evaluate pharmacokinetic drug interaction between teneligliptin and empagliflozin in healthy adults.

Key Dates

Start date
Sep 15, 2020
Status verified
Nov 2021
Primary completion
Nov 16, 2020
Completion
Jan 25, 2021

Study Design

Enrollment
32 participants (actual)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Teneligliptin
  • Experimental: Empagliflozin
  • Experimental: Teneligliptin and Empagliflozin

Primary Outcome Measure

Cmax,ss of teneligliptin and empagliflozin [ Time Frame: 72 hours ]

Related Studies